OUR PRODUCTS

MOBILE APPS

GENERAL INFO

EBS

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

Emergent Biosolutions (EBS) Ownership - Who owns Emergent Biosolutions?

Emergent BioSolutions Inc offers public health products to the government and healthcare providers... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

300 Professional Drive

Phone

+1 240 631-3200

Employees

1600

Web

https://www.emergentbiosolutions.com

Details

Group

Domestic Stock Funds

Fundamentals

EBS

Capitalization

443M

P/E Ratio

3.17

Risk (Beta)

3.33

Dividend Yield

N/A

Total Cash

267M

Total Cash/Share

5.01

Total Debt

668M

Total Debt/Equity

52.57

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

14.73%

Revenue

812M

ROE

N/A

Book Value

536M

P/B Ratio

0.83

Cash Flow

N/A

Earnings

2.66

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

100K

Current Ratio

5.66

Current Revenue Per Employee

144777.78

Dividends Per Share - Security

N/A

EBITDA

344M

Float

N/A

Float - Current

N/A

Gross Income Margin

48.66

Revenue To Assets

9.52

Shares Held By Institutions

303M

Shares Outstanding - Current

53.4M

Total Liabilities

881M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-13.180

View a ticker or compare two or three

Compare

EBS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For EBS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EBS showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a manufacturer of biopharmaceutical products

Industry PharmaceuticalsGeneric